MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP: TMDIF )

0.0405 +0.0025 (+6.58%)
Streaming Delayed Price Updated: 3:46 PM EDT, Sep 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 42,929
Open 0.0380
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0380
Today's Range 0.0380 - 0.0408
52wk Range 0.0295 - 0.1150
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Conavi Medical Shareholders Approve the Proposed Amalgamation Between Titan and Conavi
Titan’s respective annual general and special meeting of shareholders to vote on the amalgamation transaction to take place on September 30, 2024, at 4:00 p.m. Eastern Time 
From Titan Medical Inc.
Via GlobeNewswire
Proxy Deadline Thursday September 26, 2024
From Titan Medical Inc.
Via GlobeNewswire

Performance

YTD
-31.59%
-31.59%
1 Month
-1.70%
-1.70%
3 Month
+1.25%
+1.25%
6 Month
-19.64%
-19.64%
1 Year
-62.50%
-62.50%

More News

Read More
Proxy Advisor Glass, Lewis & Co., Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi
From Titan Medical Inc.
Via GlobeNewswire
Titan Announces Conavi Medical to Present Overview at Titan Q&A Session
From Titan Medical Inc.
Via GlobeNewswire
Independent Proxy Advisor, Institutional Shareholder Services (“ISS”), Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi
From Titan Medical Inc.
Via GlobeNewswire
Titan Announces Q&A Session with Shareholders
From Titan Medical Inc.
Via GlobeNewswire
Titan Announces Filing of the Management Information Circular.
From Titan Medical Inc.
Via GlobeNewswire
Titan Medical Reports Operating and Financial Results for the Second Quarter 2024
From Titan Medical Inc.
Via GlobeNewswire
Titan Further Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Further Extension of 2024 Annual General and Special Meeting
From Titan Medical Inc.
Via GlobeNewswire
Titan Amends Amalgamation Agreement with Conavi Medical Inc.
From Titan Medical Inc.
Via GlobeNewswire
Titan Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Extension of 2023 Annual General and Special Meeting
From Titan Medical Inc.
Via GlobeNewswire
Titan Provides Update on Planned Merger with Conavi
From Titan Medical Inc.
Via GlobeNewswire
Titan Medical Reports Financial Results for the First Quarter 2024
From Titan Medical Inc.
Via GlobeNewswire
Titan Provides Update on Planned Merger with Conavi
From Titan Medical Inc.
Via GlobeNewswire
Titan Settles Contractual Dispute with Contract Manufacturer
From Titan Medical Inc.
Via GlobeNewswire
Titan Medical Reports Fiscal Year 2023 Results
From Titan Medical Inc.
Via GlobeNewswire
Titan Announces Q&A Session with Shareholders
From Titan Medical Inc.
Via GlobeNewswire
Titan Announces Merger Agreement with Conavi
From Titan Medical Inc.
Via GlobeNewswire
Titan Medical to Report Year-End 2023 Financial Results on March 29, 2024
From Titan Medical Inc.
Via GlobeNewswire
Titan Medical Announces Benchmark Electronics, Inc. Purported to Terminate Agreement
From Titan Medical Inc.
Via GlobeNewswire
Titan Medical Reports Operating and Financial Results for the Third Quarter 2023
From Titan Medical Inc.
Via GlobeNewswire
Titan Medical Announces Change in Auditor
From Titan Medical Inc.
Via GlobeNewswire
Titan Medical Signs License Agreement with Auris Health, Inc.
From Titan Medical Inc.
Via GlobeNewswire
Titan Medical Announces Appointment of New Independent Member to its Board of Directors
From Titan Medical Inc.
Via GlobeNewswire
Titan Medical Reports Operating and Financial Results for the Second Quarter 2023
From Titan Medical Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story